Armistice Capital »

Nls Pharmaceutics shares owned by Armistice Capital

Quarter-by-quarter ownership of Nls Pharmaceutics (NLSPW) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Nls Pharmaceutics

Tip: Access up to 7 years of quarterly data

All positions including Nls Pharmaceutics held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nls Pharmaceutics by Armistice Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $53k 500k 0.11
2023-06-30 $54k 500k 0.11
2023-03-31 $75k 500k 0.15
2022-12-31 $145k 500k 0.29
2022-09-30 $125k 500k 0.25
2022-03-31 $190k 500k 0.38
2021-12-31 $250k 500k 0.50
2021-09-30 $413k 500k 0.83
2021-06-30 $452k 500k 0.90
2021-03-31 $475k 500k 0.95

More positions owned by Armistice Capital

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Argenx Se Sponsored Adr (ARGX)
Supernus Pharmaceuticals (SUPN)
Ptc Therapeutics I (PTCT)
Neurocrine Biosciences (NBIX)
Agios Pharmaceuticals (AGIO)
Biogen Idec (BIIB)
Colgate-Palmolive Company (CL)
Travere Therapeutics (TVTX)
Nevro (NVRO)
Amazon (AMZN)
Dentsply Sirona (XRAY)
Regeneron Pharmaceuticals (REGN)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Armistice Capital

Top funds holding Nls Pharmaceutics

Hudson Bay Capital Management
Susquehanna International
UBS Group

View all funds holding Nls Pharmaceutics